Methadone in the Intrathecal Treatment of Chronic Nonmalignant Pain Resistant to Other Neuroaxial Agents: The First Experience
- 1 January 2001
- journal article
- research article
- Published by Elsevier in Neuromodulation: Technology at the Neural Interface
- Vol. 4 (1) , 25-32
- https://doi.org/10.1046/j.1525-1403.2001.00025.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Preclinical Toxicity Study of Intrathecal Administration of the Pain Relievers Dextrorphan, Dextromethorphan, and Memantine in the Sheep ModelNeuromodulation: Technology at the Neural Interface, 1999
- Alternative Intrathecal Agents for the Treatment of PainNeuromodulation: Technology at the Neural Interface, 1999
- Intraspinal morphine for chronic pain: A retrospective, multicenter studyJournal of Pain and Symptom Management, 1996
- Long-term intraspinal infusions of opioids in the treatment of neuropathic painJournal of Pain and Symptom Management, 1995
- Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonistsPain, 1994
- Intrathecal infusional analgesia for nonmalignant pain: Analgesic efficacy of intrathecal opioid with or without bupivacaineJournal of Pain and Symptom Management, 1993
- Methadone in pain uncontrolled by morphineThe Lancet, 1993
- Intrathecal infusional therapies for intractable pain: Patient management guidelinesJournal of Pain and Symptom Management, 1993
- Paradoxical painThe Lancet, 1992
- Morphine-3-glucuronide - a potent antagonist of morphine analgesiaLife Sciences, 1990